GOFCX
Price
$27.71
Change
-$0.06 (-0.22%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

GOFCX vs RPTIX

Header iconGOFCX vs RPTIX Comparison
Open Charts GOFCX vs RPTIXBanner chart's image
Pioneer Select Mid Cap Growth C
Price$27.71
Change-$0.06 (-0.22%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GOFCX vs RPTIX Comparison Chart
Loading...
VS
GOFCX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOFCX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. GOFCX (1.46B). RPTIX pays higher dividends than GOFCX: RPTIX (0.18) vs GOFCX (0.00). GOFCX was incepted earlier than RPTIX: GOFCX (23 years) vs RPTIX (9 years). GOFCX is a more actively managed with annual turnover of: 72.00 vs. RPTIX (21.70). GOFCX has a lower initial minimum investment than RPTIX: GOFCX (1000) vs RPTIX (500000). GOFCX annual gain was more profitable for investors over the last year : 32.87 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. GOFCX (-5.77).
GOFCXRPTIXGOFCX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD16.3879.127180%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B31.4B5%
Annual Yield % from dividends0.000.18-
Returns for 1 year32.8714.81222%
Returns for 3 years-25.61-13.57189%
Returns for 5 years-5.7715.09-38%
Returns for 10 years-18.52N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp